Patent details

EP2807188 Title: HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN

Basic Information

Publication number:
EP2807188
PCT Application Number:
US2013023307
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137408712
PCT Publication Number:
WO2013112945
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN
French Title of Invention:
ANTICORPS HUMANISÉS QUI RECONNAISSENT L'ALPHA-SYNUCLÉINE
German Title of Invention:
ALPHA-SYNUCLEIN ERKENNENDE HUMANISIERTE ANTIKÖRPER
SPC Number:

Dates

Filing date:
25/01/2013
Grant date:
11/09/2019
EP Publication Date:
03/12/2014
PCT Publication Date:
01/08/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/09/2019
EP B1 Publication Date:
11/09/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/01/2020
Expiration date:
25/01/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/09/2019
 
 

Name:
Prothena Biosciences Limited
Address:
77 Sir Rogerson's Quay Block C Grand Canal Docklands, Dublin 2, D02 T804, Ireland (IE)

Inventor

1

Name:
NIJJAR, Tarlochan S.
Address:
United States (US)

2

Name:
SALDANHA, Jose
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201261591835 P
Priority Date:
27/01/2012
Priority Country:
United States (US)

2

Priority Number:
201261711207 P
Priority Date:
08/10/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61K 49/00; A61K 49/16; A61K 51/10; C07K 16/18;

Publication

European Patent Bulletin

Issue number:
201937
Publication date:
11/09/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages